iCoreConnect Inc（ICCT）股票分析

$1.860

-0.322 (-17.33%)收盤時

Loading chart…

High: 2.287
Open: 2.280
VWAP: 1.98
Vol: 1.69M
Mkt Cap: 9.61M
Low: 1.800
Amount: 3.35M
EV/EBITDA, TTM: 0.00

iCoreConnect Inc. is a cloud-based software and technology company. The Company is focused on increasing workflow productivity and practice profitability through its enterprise and healthcare workflow platform of applications and services. The Company is primarily engaged in providing solutions to solve the healthcare business problems. iCoreConnect touts a platform of over 16 software-as-a-service (SaaS) enterprise solutions and more than 100 agreements with state or regional healthcare associations across the United States. It offers solutions for the dental, medical and business information technology (IT) sectors. The Company offers cloud-based SaaS offering under the names of iCoreRx, iCorePDMP, iCoreEPCS, iCoreVerify, iCoreVerify+, iCoreHuddle, iCoreHuddle+, iCoreCodeGenius, iCoreExchange, iCoreCloud, iCorePay, iCoreSecure, iCoreClaims, iCoreHIPAA, iCoreAcademy and iCoreIT. iCoreRx is an e-prescribing solution to improve efficiency, resource utilization, and patient safety.

www.icoreconnect.com

估值指標

The current forward P/E ratio for iCoreConnect Inc (ICCT) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued

5Y Average P/E

0.00

Current P/E

0.00

高估

0.00

低估

0.00

Forward EV/EBITDA

Fair

5Y Average EV/EBITDA

15.84

Current EV/EBITDA

0.00

高估

54.25

低估

-22.56

Forward P/S

Fair

5Y Average P/S

1.44

Current P/S

0.00

高估

4.93

低估

-2.05

事件時間軸

2024-12-19 (ET)

07:38:43

iCoreConnect announces 1-for-20 reverse stock split

2024-11-25 (ET)

07:38:57

iCoreConnect announes expansion of partnership with MSDA

2024-11-21 (ET)

07:36:17

iCoreConnect reports Q3 revenue $2.788M vs $2M last year

2024-11-14 (ET)

07:50:52

iCoreConnect announces new endorsement agreement with NDDA

2024-10-09 (ET)

08:38:54

iCoreConnect announces new endorsement agreemenet with DSDS

Show More Events

資訊

ICCT FAQ — answered by Alphio AI

iCoreConnect Inc. is a cloud-based software and technology company. The Company is focused on increasing workflow productivity and practice profitability through its enterprise and healthcare workflow platform of applications and services. The Company is primarily engaged in providing solutions to solve the healthcare business problems. iCoreConnect touts a platform of over 16 software-as-a-service (SaaS) enterprise solutions and more than 100 agreements with state or regional healthcare associations across the United States. It offers solutions for the dental, medical and business information technology (IT) sectors. The Company offers cloud-based SaaS offering under the names of iCoreRx, iCorePDMP, iCoreEPCS, iCoreVerify, iCoreVerify+, iCoreHuddle, iCoreHuddle+, iCoreCodeGenius, iCoreExchange, iCoreCloud, iCorePay, iCoreSecure, iCoreClaims, iCoreHIPAA, iCoreAcademy and iCoreIT. iCoreRx is an e-prescribing solution to improve efficiency, resource utilization, and patient safety. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).

本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。